KK
VIR icon

KLP Kapitalforvaltning’s Vir Biotechnology VIR Stock Holding History

KLP Kapitalforvaltning’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Buy
30,900
+11,500
+59% +$91.6K ﹤0.01% 1693
2025
Q4 		$117K Buy
19,400
+3,200
+20% +$19.1K ﹤0.01% 2029
2025
Q3 		$92.5K Hold
16,200
– – ﹤0.01% 2077
2025
Q2 		$81.6K Hold
16,200
– – ﹤0.01% 2091
2025
Q1 		$105K Hold
16,200
– – ﹤0.01% 2010
2024
Q4 		$119K Buy
+16,200
New +$128K ﹤0.01% 2022

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return